{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:15:17Z","timestamp":1791281717774,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.ymgme.2007.07.009","type":"journal-article","created":{"date-parts":[[2007,9,8]],"date-time":"2007-09-08T11:19:13Z","timestamp":1189250353000},"page":"299-307","source":"Crossref","is-referenced-by-count":29,"title":["Pompe disease: Current state of treatment modalities and animal models"],"prefix":"10.1016","volume":"92","author":[{"given":"T.M.","family":"Geel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.J.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.F.M.H.","family":"de Leij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.H.J.","family":"Ruiters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.E.","family":"Niezen-Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2007.07.009_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2007.07.009_bib2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/sj.ejhg.5200367","article-title":"Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling","volume":"7","author":"Ausems","year":"1999","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2007.07.009_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1096-8628(19980827)79:1<69::AID-AJMG16>3.0.CO;2-K","article-title":"Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease","volume":"79","author":"Martiniuk","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ymgme.2007.07.009_bib4","first-page":"304","article-title":"Over idiopatische hypertrofie van het hart","volume":"76","author":"Pompe","year":"1932","journal-title":"Ned. Tijdsch. Geneesk."},{"key":"10.1016\/j.ymgme.2007.07.009_bib5","first-page":"145","article-title":"Glycogen structure and enzyme deficiencies in glycogen storage disease","volume":"48","author":"Cori","year":"1952","journal-title":"Harvey Lect."},{"key":"10.1016\/j.ymgme.2007.07.009_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/bj0860011","article-title":"Alpha-glucosidase deficiency in generalized glycogenstorage disease (Pompe\u2019s disease)","volume":"86","author":"Hers","year":"1963","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2007.07.009_bib7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/brain\/93.3.599","article-title":"Acid maltase deficiency in adults: studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies","volume":"93","author":"Engel","year":"1970","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2007.07.009_bib8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM198602063140611","article-title":"Bone marrow transplantation for glycogen storage disease type II (Pompe\u2019s disease)","volume":"314","author":"Watson","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2007.07.009_bib9","first-page":"184","article-title":"Enzyme replacement in Pompe disease: an attempt with purified human acid alpha-glucosidase","volume":"9","author":"de Barsy","year":"1973","journal-title":"Birth Defects Orig. Artic. Ser."},{"key":"10.1016\/j.ymgme.2007.07.009_bib10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1172\/JCI115025","article-title":"Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice","volume":"87","author":"van der Ploeg","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2007.07.009_bib11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00125817-200103000-00008","article-title":"Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial","volume":"3","author":"Amalfitano","year":"2001","journal-title":"Genet. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2007.07.009_bib12","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1007\/BF02680006","article-title":"Enzyme therapy for Pompe disease: from science to industrial enterprise","volume":"161","author":"Reuser","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2007.07.009_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(00)02533-2","article-title":"Recombinant human alpha-glucosidase from rabbit milk in Pompe patients","volume":"356","author":"Van den Hout","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2007.07.009_bib14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1042\/BJ20050364","article-title":"Carbohydrate-remodelled acid alpha-glucosidase with higher affinity for the cation-independent mannose 6-phosphate receptor demonstrates improved delivery to muscles of Pompe mice","volume":"389","author":"Zhu","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2007.07.009_bib15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/dna.1991.10.283","article-title":"Isolation and partial characterization of the structural gene for human acid alpha glucosidase","volume":"10","author":"Martiniuk","year":"1991","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.ymgme.2007.07.009_bib16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/oxfordjournals.jbchem.a122457","article-title":"Intracellular transport of acid alpha-glucosidase in human fibroblasts: evidence for involvement of phosphomannosyl receptor-independent system","volume":"104","author":"Tsuji","year":"1988","journal-title":"J. Biochem. (Tokyo)"},{"key":"10.1016\/j.ymgme.2007.07.009_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0304-4165(88)90030-X","article-title":"Glucocerebrosidase, a lysosomal enzyme that does not undergo oligosaccharide phosphorylation","volume":"964","author":"Aerts","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2007.07.009_bib18","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1002\/j.1460-2075.1994.tb06648.x","article-title":"Differential sorting of lysosomal enzymes in mannose 6-phosphate receptor-deficient fibroblasts","volume":"13","author":"Ludwig","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.ymgme.2007.07.009_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1566524024605789","article-title":"Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease)","volume":"2","author":"Raben","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.ymgme.2007.07.009_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1357-4310(00)01694-4","article-title":"Towards a molecular therapy for glycogen storage disease type II (Pompe disease)","volume":"6","author":"Chen","year":"2000","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.ymgme.2007.07.009_bib21","series-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"Hirschhorn","year":"2001"},{"key":"10.1016\/j.ymgme.2007.07.009_bib22","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1002\/mus.880181414","article-title":"Glycogenosis type II (acid maltase deficiency)","volume":"3","author":"Reuser","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2007.07.009_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/mgme.2000.3003","article-title":"Approach to gene therapy of glycogenosis type II (Pompe disease)","volume":"70","author":"Poenaru","year":"2000","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2007.07.009_bib24","series-title":"Glycogen storage disease type II: acid alpha glucosidase (acid maltase) deficiency","author":"Hirschhorn","year":"1995"},{"key":"10.1016\/j.ymgme.2007.07.009_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0022-510X(76)90263-X","article-title":"Acid maltase deficiency (type II glycogenosis). Morphological and biochemical study of a childhood phenotype","volume":"30","author":"Martin","year":"1976","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2007.07.009_bib26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/humu.10286","article-title":"Twenty-two novel mutations in the lysosomal alpha-glucosidase gene (GAA) underscore the genotype\u2013phenotype correlation in glycogen storage disease type II","volume":"23","author":"Hermans","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2007.07.009_bib27","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1212\/WNL.55.8.1122","article-title":"Juvenile and adult-onset acid maltase deficiency in France: genotype\u2013phenotype correlation","volume":"55","author":"Laforet","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2007.07.009_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/mgme.2001.3227","article-title":"Consequences of complexity within biological networks: robustness and health, or vulnerability and disease","volume":"74","author":"Dipple","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2007.07.009_bib29","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ana.20807","article-title":"Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease","volume":"59","author":"Fukuda","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2007.07.009_bib30","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","article-title":"Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease","volume":"86","author":"Thurberg","year":"2006","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ymgme.2007.07.009_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/hmg\/7.1.53","article-title":"Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease","volume":"7","author":"Bijvoet","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2007.07.009_bib32","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","article-title":"Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II","volume":"273","author":"Raben","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2007.07.009_bib33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0960-8966(99)00117-0","article-title":"Modulation of disease severity in mice with targeted disruption of the acid alpha-glucosidase gene","volume":"10","author":"Raben","year":"2000","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2007.07.009_bib34","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/(SICI)1098-1004(1997)10:2<128::AID-HUMU5>3.0.CO;2-G","article-title":"Glycogenosis type II: a juvenile-specific mutation with an unusual splicing pattern and a shared mutation in African Americans","volume":"10","author":"Adams","year":"1997","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2007.07.009_bib35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/A:1022998010833","article-title":"Induction of tolerance to a recombinant human enzyme, acid alpha-glucosidase, in enzyme deficient knockout mice","volume":"12","author":"Raben","year":"2003","journal-title":"Transgenic Res."},{"key":"10.1016\/j.ymgme.2007.07.009_bib36","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/hmg\/10.19.2039","article-title":"Conditional tissue-specific expression of the acid alpha-glucosidase (GAA) gene in the GAA knockout mice: implications for therapy","volume":"10","author":"Raben","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2007.07.009_bib37","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/sj.gt.3302314","article-title":"Improved efficacy of gene therapy approaches for Pompe disease using a new, immune-deficient GSD-II mouse model","volume":"11","author":"Xu","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2007.07.009_bib38","first-page":"1139","article-title":"An electron microscopic and biochemical study of type II glycogenosis","volume":"13","author":"Baudhuin","year":"1964","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ymgme.2007.07.009_bib39","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1083\/jcb.35.1.C1","article-title":"Lysosomes in type II glycogenosis. Changes during administration of extract from Aspergillus niger","volume":"35","author":"Hug","year":"1967","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymgme.2007.07.009_bib40","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/hmg\/8.12.2145","article-title":"Human acid alpha-glucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II","volume":"8","author":"Bijvoet","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2007.07.009_bib41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1073\/pnas.93.1.65","article-title":"High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease","volume":"93","author":"Van Hove","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2007.07.009_bib42","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1016\/S0021-9258(18)53985-5","article-title":"Structural and functional changes of lysosomal acid alpha-glucosidase during intracellular transport and maturation","volume":"268","author":"Wisselaar","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2007.07.009_bib43","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1172\/JCI1722","article-title":"Clinical and metabolic correction of Pompe disease by enzyme therapy in acid maltase-deficient quail","volume":"101","author":"Kikuchi","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2007.07.009_bib44","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/hmg\/7.11.1815","article-title":"Recombinant human acid alpha-glucosidase: high level production in mouse milk, biochemical characteristics, correction of enzyme deficiency in GSDII KO mice","volume":"7","author":"Bijvoet","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2007.07.009_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0167-4781(96)00093-0","article-title":"Expression of cDNA-encoded human acid alpha-glucosidase in milk of transgenic mice","volume":"1308","author":"Bijvoet","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2007.07.009_bib46","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1203\/00006450-199803000-00011","article-title":"Recombinant human acid alpha-glucosidase corrects acid alpha-glucosidase-deficient human fibroblasts, quail fibroblasts, and quail myoblasts","volume":"43","author":"Yang","year":"1998","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2007.07.009_bib47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymthe.2004.09.017","article-title":"Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers","volume":"11","author":"Raben","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2007.07.009_bib48","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1023\/A:1010383421286","article-title":"Enzyme therapy for Pompe disease with recombinant human alpha-glucosidase from rabbit milk","volume":"24","author":"Van den Hout","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2007.07.009_bib49","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk","volume":"113","author":"Van den Hout","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2007.07.009_bib50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nmd.2004.10.009","article-title":"Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial","volume":"15","author":"Klinge","year":"2005","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2007.07.009_bib51","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.1542\/peds.2003-0988-L","article-title":"Nephrotic syndrome complicating alpha-glucosidase replacement therapy for Pompe disease","volume":"114","author":"Hunley","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2007.07.009_bib52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid-alpha-glucosidase. Major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2007.07.009_bib53","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","article-title":"Enzyme replacement therapy in the mouse model of Pompe disease","volume":"80","author":"Raben","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2007.07.009_bib54","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ymthe.2006.08.009","article-title":"Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease","volume":"14","author":"Fukuda","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2007.07.009_bib55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ymgme.2006.09.010","article-title":"Chemical chaperones improve transport and enhance stability of mutant alpha-glucosidases in glycogen storage disease type II","volume":"90","author":"Okumiya","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2007.07.009_bib56","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.mt.6300074","article-title":"Pharmacological enhancement of mutated alpha-glucosidase activity in fibroblasts from patients with Pompe disease","volume":"15","author":"Parenti","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2007.07.009_bib57","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/hmg\/7.11.1695","article-title":"Adenovirus-mediated transfer of the acid alpha-glucosidase gene into fibroblasts, myoblasts and myotubes from patients with glycogen storage disease type II leads to high level expression of enzyme and corrects glycogen accumulation","volume":"7","author":"Nicolino","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2007.07.009_bib58","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1089\/104303401300042447","article-title":"Intercellular transfer of the virally derived precursor form of acid alpha-glucosidase corrects the enzyme deficiency in inherited cardioskeletal myopathy Pompe disease","volume":"12","author":"Pauly","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2007.07.009_bib59","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1073\/pnas.96.16.8861","article-title":"Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid\u2013alpha-glucosidase","volume":"96","author":"Amalfitano","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2007.07.009_bib60","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1525-0016(02)90716-1","article-title":"Glycogen stored in skeletal but not in cardiac muscle in acid alpha-glucosidase mutant (Pompe) mice is highly resistant to transgene-encoded human enzyme","volume":"6","author":"Raben","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2007.07.009_bib61","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1006\/mthe.2002.0563","article-title":"Efficacy of gene therapy for a prototypical lysosomal storage disease (GSD-II) is critically dependent on vector dose, transgene promoter, and the tissues targeted for vector transduction","volume":"5","author":"Ding","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2007.07.009_bib62","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/hmg\/11.14.1637","article-title":"Muscle as a putative producer of acid alpha-glucosidase for glycogenosis type II gene therapy","volume":"11","author":"Martin-Touaux","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2007.07.009_bib63","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1006\/mthe.2002.0580","article-title":"Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors","volume":"5","author":"Fraites","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2007.07.009_bib64","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/104303401750061267","article-title":"Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies","volume":"12","author":"Cordier","year":"2001","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2007.07.009_bib65","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ymthe.2003.11.015","article-title":"AAV2 vector harboring a liver-restricted promoter facilitates sustained expression of therapeutic levels of alpha-galactosidase A and the induction of immune tolerance in Fabry mice","volume":"9","author":"Ziegler","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2007.07.009_bib66","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ymthe.2005.01.012","article-title":"Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter","volume":"11","author":"Sun","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2007.07.009_bib67","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ymthe.2005.04.024","article-title":"Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II","volume":"12","author":"Franco","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2007.07.009_bib68","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrc1122","article-title":"Occurrence of leukaemia following gene therapy of X-linked SCID","volume":"3","author":"Kohn","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ymgme.2007.07.009_bib69","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/10430340152712719","article-title":"A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency","volume":"13","author":"Raper","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2007.07.009_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2003.09.013","article-title":"An overview of current delivery systems in cancer gene therapy","volume":"94","author":"El Aneed","year":"2004","journal-title":"J. Control Release"},{"key":"10.1016\/j.ymgme.2007.07.009_bib71","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1096\/fj.02-0127hyp","article-title":"Design of a nonviral vector for site-selective, efficient integration into the human genome","volume":"16","author":"Kaminski","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.ymgme.2007.07.009_bib72","first-page":"6909","article-title":"Lipid-mediated protein delivery of suicide nucleoside kinases","volume":"63","author":"Zheng","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymgme.2007.07.009_bib73","doi-asserted-by":"crossref","first-page":"35103","DOI":"10.1074\/jbc.M104920200","article-title":"Intracellular delivery of proteins with a new lipid-mediated delivery system","volume":"276","author":"Zelphati","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2007.07.009_bib74","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/B:NEON.0000003655.03671.fa","article-title":"Clinical gene therapy for brain tumors. Liposomal delivery of anticancer molecule to glioma","volume":"65","author":"Yoshida","year":"2003","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.ymgme.2007.07.009_bib75","first-page":"1","article-title":"Cationic liposomes-promising gene carriers in non-viral gene therapy","author":"Chaudhuri","year":"2002","journal-title":"Pharmatechnology"},{"key":"10.1016\/j.ymgme.2007.07.009_bib76","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature03556","article-title":"Highly efficient endogenous human gene correction using designed zinc-finger nucleases","volume":"435","author":"Urnov","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ymgme.2007.07.009_bib77","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ymthe.2005.06.094","article-title":"Custom zinc-finger nucleases for use in human cells","volume":"12","author":"Alwin","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2007.07.009_bib78","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ymgme.2005.10.016","article-title":"A new diagnostic assay for glycogen storage disease type II in mixed leukocytes","volume":"88","author":"Okumiya","year":"2006","journal-title":"Mol. Genet. Metab."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719207002478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719207002478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T04:53:45Z","timestamp":1629694425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719207002478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S1096719207002478"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2007.07.009","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}